Texas 2023 - 88th Regular

Texas House Bill HB4428 Compare Versions

OldNewDifferences
11 88R11792 MCF-D
22 By: Garcia H.B. No. 4428
33
44
55 A BILL TO BE ENTITLED
66 AN ACT
77 relating to the scheduling of certain controlled substances in
88 response to certain actions by the United States Food and Drug
99 Administration with respect to those substances.
1010 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1111 SECTION 1. Section 481.034, Health and Safety Code, is
1212 amended by amending Subsections (a), (b), and (g) and adding
1313 Subsection (g-1) to read as follows:
1414 (a) The commissioner shall annually establish the schedules
1515 of controlled substances. These annual schedules shall include the
1616 complete list of all controlled substances from the previous
1717 schedules and modifications in the federal schedules of controlled
1818 substances as required by Subsection (g) or (g-1). Any further
1919 additions to and deletions from these schedules, any rescheduling
2020 of substances, and any other modifications made by the commissioner
2121 to these schedules of controlled substances shall be made:
2222 (1) in accordance with Section 481.035;
2323 (2) in a manner consistent with this subchapter; and
2424 (3) with approval of the executive commissioner.
2525 (b) Except for alterations in schedules required by
2626 Subsection (g) or (g-1), the commissioner may not make an
2727 alteration in a schedule unless the commissioner holds a public
2828 hearing on the matter in Austin and obtains approval from the
2929 executive commissioner.
3030 (g) Except as otherwise provided by this subsection or
3131 Subsection (g-1), if a substance is designated, rescheduled, or
3232 deleted as a controlled substance under federal law and notice of
3333 that fact is given to the commissioner, the commissioner similarly
3434 shall control the substance under this chapter. After the
3535 expiration of a 30-day period beginning on the day after the date of
3636 publication in the Federal Register of a final order designating a
3737 substance as a controlled substance or rescheduling or deleting a
3838 substance, the commissioner similarly shall designate, reschedule,
3939 or delete the substance, unless the commissioner objects during the
4040 period. If the commissioner objects, the commissioner shall
4141 publish the reasons for the objection and give all interested
4242 parties an opportunity to be heard. At the conclusion of the
4343 hearing, the commissioner shall publish a decision, which is final
4444 unless altered by statute. On publication of an objection by the
4545 commissioner, control as to that particular substance under this
4646 chapter is stayed until the commissioner publishes the
4747 commissioner's decision.
4848 (g-1) If a controlled substance listed in Schedule I is
4949 approved by the United States Food and Drug Administration under
5050 Section 505, Federal Food, Drug, and Cosmetic Act (21 U.S.C.
5151 Section 355), the substance is subsequently deleted as a controlled
5252 substance or rescheduled and placed on a lower schedule under
5353 federal law, and notice of those facts is given to the commissioner,
5454 as soon as practicable the commissioner similarly shall delete or
5555 reschedule the substance under this chapter.
5656 SECTION 2. The changes in law made by this Act apply only to
5757 a controlled substance deleted as a controlled substance or
5858 rescheduled and placed on a lower schedule under federal law on or
5959 after the effective date of this Act.
6060 SECTION 3. This Act takes effect September 1, 2023.